ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1093

DNA Methylation Defines Joint Specific Differences in Synovial Fibroblasts  from OA and RA Patients

Emmanuel Karouzakis1, Mojca Frank Bertoncelj2, Kerstin Klein1, Christoph Kolling3, Renate E. Gay1, Steffen Gay1 and Caroline Ospelt1, 1Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 3Schulthess Clinic, Zurich, Switzerland

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Epigenetics, Osteoarthritis, rheumatoid arthritis (RA) and synovial cells, synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Biology and Pathology of Bone and Joint - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Recent studies revealed epigenetic changes in DNA methylation associated with rheumatoid arthritis (RA) synovial fibroblasts (SF). In addition, we have shown that SF exhibit large anatomic differences in their epigenome, transcriptome and function. Here, we investigated the role of DNA methylation in the regulation of joint specific gene expression.

Methods: RNA and DNA were isolated from cultured SF obtained from hands (n= 1 OA/4 RA), shoulders (n = 3 OA/4 RA) and knees (n = 1 OA/4 RA) of RA and OA patients. RNA sequencing (Illumina HiSeq2000) of SF was used to identify differentially expressed genes (n=3 for each joint and condition). DNA from the same samples was subjected to the Illumina HumanMethylation 450 array. After quality control, we calculated differentially methylated CpG sites and islands using the COHCAP Bioconductor package (version 3.3) in R statistical program.

Results: We compared the methylation profile of the following joints shoulder-hand, knee-hand and knee-shoulder. The analysis identified 66, 32 and 64 differentially methylated CpG sites, respectively (methylated beta > 0.7 and unmethylated beta <0.3, p<0.05, FDR <0.05). Principal component analysis showed clustering of samples in relation to the joint localization. In detail, we found 40 CpG sites to be hypomethylated and 26 hypermethylated in hand compared to shoulder SF. Of these, 13 and 6 CpG sites were hypomethylated on the CpG island of lncRNAs HOXA11AS and LOC145845. 8 hypermethylated CpG sites were found on the CpG island of MEIS1 in hand. In hand versus knee SF 28 CpG sites were hypomethylated and 4 hypermethylated. Of these, 5 CpG sites were hypomethylated on the gene body of the lncRNA HOTAIR and 4 CpG sites along the region of HOXC6, C5, C4 genes in hand. Last, we compared SF of shoulders versus knees and identified 51 hypomethylated and 13 hypermethylated CpG sites. Of these, 4 CpG sites were hypomethylated on the CpG island of HAND2 and 5 hypomethylated CpG sites were spread along the MEIS1 gene body in shoulders. Functional annotation analysis revealed that the majority of differential methylated genes are associated with limb development. The grade of DNA methylation matched the expression of most but not all differentially methylated genes, pointing to other regulating mechanisms of joint specific transcription. HOXA11-AS was higher (log2 ratio 2.89, p=1.18×10-23) and MEIS1 lower expressed in hand than in shoulder SF (log2 ratio -1.63, p=2.77×10-21). Expression of LOC145845 was not detectable. HOTAIR and HOXC6, C5, C4 were however overexpressed in knee compared to hand SF (log2 ratios 5.85, 3.04, 3.23, 3.08, p<5.6×10-21). Expression of HAND2 (log2 ratio 3.13, p=3.53×10-8) and also MEIS1 (log2 ratio 0.94, p=1.52×10-5) was increased in shoulder compared to knee SF.

Conclusion: We show that DNA methylation regulates the expression of genes in a joint specific manner. These results point towards a fundamental role of epigenetics in maintaining location specific identities in joint stromal cells. We suggest that these joint specific differences in gene expression mediate the occurrence of distinct patterns of joint involvement in the development of arthritides.


Disclosure: E. Karouzakis, None; M. Frank Bertoncelj, None; K. Klein, None; C. Kolling, None; R. E. Gay, None; S. Gay, None; C. Ospelt, None.

To cite this abstract in AMA style:

Karouzakis E, Frank Bertoncelj M, Klein K, Kolling C, Gay RE, Gay S, Ospelt C. DNA Methylation Defines Joint Specific Differences in Synovial Fibroblasts  from OA and RA Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/dna-methylation-defines-joint-specific-differences-in-synovial-fibroblasts-from-oa-and-ra-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dna-methylation-defines-joint-specific-differences-in-synovial-fibroblasts-from-oa-and-ra-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology